Response of primed human PBMC to synthetic peptides derived from hepatitis B virus envelope proteins: A search for promiscuous epitopes

FEMS Immunology and Medical Microbiology

Volumn 35, Issue 1, 2003, Pages 77-85

  Doh, Hyounmie ^a   Roh, Sujin ^a   Lee, Kyung Wha ^b   Kim, Kilhyoun ^a  

^a Ewha Womans University   (South Korea)

^b Hallym University   (South Korea)

Author keywords

Hepatitis B virus; Peripheral blood mononuclear cell; T helper epitope

Indexed keywords

AMINO ACID; EPITOPE; HLA ANTIGEN CLASS 2; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

ALLELE; ARTICLE; CONTROLLED STUDY; HELPER CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOGENICITY; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0037458532     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(02)00461-3     Document Type: Article

References (47)

1. Chisari F.V., Ferrari C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:1995;29-60.
2. Nossal, G.J.V. (1999) Vaccines. In: Fundamental Immunology (Paul, W.E., Ed.), pp. 1387-1425. Lippincott-Raven Press, New York.
3. Alexander J., Fikes J., Hoffman S., Franke E., Sacci J., Appella E., Chisari F.V., Guidotti L.G., Chesnut R.W., Livingston B., Sette A. The optimization of helper T lymphocyte (HTL) function in vaccine development. Immunol. Res. 18:1998;79-92.
4. Gilles P.N., Fey G., Chisari F.V. Tumor necrosis factor-α negatively regulates hepatitis B virus gene expression in transgenic mice. J. Virol. 66:1992;3955-3960.
5. Guidotti L.G., Ando K., Hobbs M.V., Ishikawa T., Runkel L., Schreiber R.D., Chisari F.V. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA. 91:1994;3764-3768.
6. Lee H.G., Lim J.S., Lee K.Y., Choi Y.K., Choe I.S., Chung T.W., Kim K. Peptide-specific CTL induction in HBV-seropositive PBMC by stimulation with peptides in vivo: novel epitopes identified from chronic carriers. Virus Res. 50:1997;185-194.
7. Celis E., Ou D., Otvos L. Jr. Recognition of hepatitis B surface antigen by human T lymphocytes: Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides. J. Immunol. 140:1988;1808-1815.
8. Mishira A., Rao K.V.S., Durgapal H., Manivel V., Panda S.K. Human T-helper cell responses to a synthetic peptide derived from the hepatitis B surface antigen. Immunology. 79:1993;362-367.
9. Isaguliants M.G., Kadoshnikov Y.P., Kalinia T.I., Smirnov V.D., Wahren B. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits. Biochemistry. 63:1998;551-558.
10. Couillin I., Pol S., Mancini M., Driss F., Brechot C., Tiollais P., Michel M.L. Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens. J. Infect. Dis. 180:1999;15-26.
11. Celis E., Kung P.C., Chang T.W. Hepatitis B Virus-reactive human T lymphocyte clones: Antigen specificity and helper function for antibody synthesis. J. Immunol. 132:1984;1511-1516.
12. Ferrari C., Cavalli A., Penna A., Valli A., Bertoletti A., Pedretti G., Pilli M., Vitali P., Neri T.M., Giuberti T., et al. Fine specificity of the human T cell response to hepatitis B virus PreS 1 antigen. Gastroenterology. 103:1992;255-263.
13. Greenstein J.L., Schad V.C., Goodwin W.H., Brauer A.B., Bollinger B.K., Chin R.D., Kuo M.C. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIVgp 120. J. Immunol. 148:1992;3970-3977.
14. Milich D.R., McLachlan A., Chisari F.V., Kent S.B.H., Thornton G.B. Immune response to the Pre-S (1) region of the hepatitis B surface antigen (HBsAg): a Pre-S (1)-specific T cell response can bypass nonresponsiveness to the Pre-S (2) and S regions of HBsAg. J. Immunol. 137:1986;315-322.
15. Ferrari C., Penna A., Bertoletti A., Cavalli A., Valli A., Schianchi C., Fiaccadori F. The PreS antigen of Hepatitis B Virus is highly immunogenic at the T cell level in man. J. Clin. Invest. 84:1989;1314-1319.
16. Rammensee H.G., Friede T., Stevanovie S. MHC ligands and peptide motifs: First listing. Immunogenetics. 41:1995;178-228.
17. Hunt D.F., Henderson R.A., Shabanowitz J., Sakaguchi K., Michel H., Sevilir N., Cox A.L., Appella E., Engelhard V.H. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science. 255:1992;1261-1263.
18. Falk K., Rötzschke O., Stefanovic S., Jung G., Rammensee H.G. Allele-specific motifs revealed by sequencing of self peptides eluted from MHC molecules. Nature. 351:1991;290-296.
19. Rotzschke O., Falk K., Deres K., Schild H., Norda M., Metzger J., Jung G., Rammensee H.G. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature. 348:1990;252-254.
20. Chicz R.M., Urban R.G., Lane W.S., Gorga J.C., Stern L.J., Vignali D.A., Strominger J.L. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature. 358:1992;764-768.
21. Vignali D.A., Urban R.G., Chictz R.M., Strominger J.L. Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules. Eur. J. Immunol. 23:1993;1602-1607.
22. Rötzschke O., Falk K. Origin, structure and motifs of naturally processed MHC class II ligands. Curr. Opin. Immunol. 6:1994;45-51.
23. Ono Y., Ondo H., Sasado R., Igarashi K., Sugino Y., Nishioka K. The complete nucleotide sequences of the cloned hepatitis B virus DNA: subtype adr and adw. Nucleic Acids Res. 11:1983;1747-1757.
24. Kimura A., Dong R.P., Harada H., Sasazuki T. DNA typing of HLA class II genes in B-lymphoblastoid cell lines homozygous for HLA. Tissue Antigens. 40:1992;5-12.
25. Lee K.W., Jung K.S., Choi E.S. Pulmonary tuberculosis is not associated with HLA-DR phenotypes in the Korean population. Kor. J. Clin. Pathol. 13:1993;643-651.
26. Wade J.A., Hurley C.K., Hastings A., Ehrenberg P., Johnson A.H., Martell R.W., du Toit E.D. Combinational diversity in DR2 haplotype. Tissue Antigens. 41:1993;113-118.
27. Lee K.W., Cho H.C. Reverse-SSO hybridization provides an accurate and simple HLA-DR typing - A comparative study with HLA-DR serologic typing. Kor. J. Med. Sci. 9:1994;414-426.
28. Shaffer A.L., Falk-Wade J.A., Tortorelli V., Cigan A., Carter C., Hassan K., Hurley C.K. HLA-DRw52-associated DRB1 alleles identification using polymerase chain reaction-amplified DNA, sequence-specific oligonucleotide probes, and a chemiluminescent detection system. Tissue Antigens. 39:1992;84-90.
29. Salazar M., Deulofeut R., Yunis J.J., Bing D.H., Yunis E.J. A fast PCR-SSP method for HLA-DQ generic typing. Tissue Antigens. 41:1993;102-106.
30. Hammer J., Bono E., Gallazzi F., Belunis C., Nagy Z., Sinigaglia F. Precise prediction of major histocompatibility complex class II-peptide interaction processed MHC class II ligands. Curr. Opin. Immunol. 6:1993;45-51.
31. Melnick J.L., Dreesman G.R., Hollinger F.B. Approaching the control of viral hepatitis type B. J. Infect. Dis. 133:1976;210-215.
32. Tiollaris P., Charmay P., Vyas G.N. Biology of hepatitis B virus. Science. 213:1981;406-418.
33. Lim J.S., Kim S., Lee H.G., Lee K.Y., Kwon T.J., Kim K. Selection of peptides that bind to the HLA-A2.1 molecule by molecular modeling. Mol. Immunol. 33:1996;221-230.
34. Roh S., Lee Y.K., Ahn B.Y., Kim K., Moon A. Induction of CTL of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses. Virus Res. 73:2001;17-26.
35. Ahn S.H., Han K.H., Park J.Y., Lee C.K., Kang S.W., Chon C.Y., Kim Y.S., Park K., Kim D.K., Moon Y.M. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology. 31:2000;1371-1373.
36. Honorati M.C., Dolzani P., Mariani E., Piacentini A., Lisignoli G., Ferrari C., Facchini A. Epitope specificity of Th0/Th2 CD4+T-lymphocyte clones induced by vaccination with rHBsAg vaccine. Gastroenterology. 112:1997;2017-2027.
37. McDermott A.B., Cohen S.B., Zuckerman J.N., Madrigal J.A. Hepatitis B third-generation vaccines: improved response and conventional vaccine non-response - evidence for genetic basis in human. J. Viral Hepat. 5:(Suppl. 2):1998;9-11.
38. Ando K., Guidotti L.G., Wirth S., Ishikawa T., Missale G., Moriyama T., Schreiber R.D., Schlicht H.J., Huang S.N., Chisari F.V. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152:1994;3245-3253.
39. Vitiello A., Ishioka G., Grey H.M., Rose R., Farness P., LaFond R., Yuan L., Chisari F.V., Furze J., Bartholomeuz R., et al. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. J. Clin. Invest. 95:1995;341-349.
40. Livingston B.D., Crimi C., Grey H., Ishioka G., Chisari F.V., Fikes J., Grey H., Chesnut R.W., Sette A. The Hepatitis B Virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection. J. Immunol. 159:1997;1383-1392.
41. Chengalvala M.V., Bhat R.A., Bhat B.M., Vernon S.K., Lubeck M.D. Enhanced immunogenicity of hepatitis B surface antigen by insertion of a helper T cell epitope from tetanus toxoid. Vaccine. 17:1999;1035-1041.
42. Milich D.R. Influence of T-helper cell subsets and crossregulation in hepatitis B virus infection. J. Viral Hepat. 4:(Suppl. 2):1997;48-59.
43. Hultgren C., Milich D.R., Weiland O., Sallberg M. The antiviral compound ribavirin modulates the T helper (Th)1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J. Gen. Virol. 79:1998;2381-2391.
44. Bocher W.O., Galun E., Marcus H., Daudi N., Terkieltaub D., Shouval D., Lohr H.F., Reisner Y. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse. Hepatology. 31:2000;480-487.
45. Milich D.R., Peterson D.L., Schoedel F., Jones J.E., Hughes J.L. Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent. J. Virol. 69:1995;2776-2785.
46. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
47. Diepolder H.M., Jung M.C., Keller E., Schraut W., Gerlach J.T., Gruner N., Zachoval R., Hoffmann R.M., Schirren C.A., Scholz S., Pape G.R. A vigorous virus-specific CD4+T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin. Exp. Immunol. 113:1998;244-251.